Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase-3 and the microtubule-associated protein Tau in the rat cerebellum-Reference-Cited by-同舟云学术

Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase-3 and the microtubule-associated protein Tau in the rat cerebellum

Published:2007-03 Issue:4 Volume:67 Page:510-520
ISSN:1932-8451
Container-title:Developmental Neurobiology
language:en
Short-container-title:Devel Neurobio

Author:

Guerra-Araiza Christian,Amorim Miguel A.R.,Camacho-Arroyo Ignacio,Garcia-Segura Luis M.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience

Reference78 articles.

1. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis

2. Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system

3. Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease

4. Tau phosphorylation and aggregation in Alzheimer's disease pathology

5. Tau Function and Dysfunction in Neurons

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroactive steroids fluctuate with regional specificity in the central and peripheral nervous system across the rat estrous cycle;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Sex-associated microRNAs potentially implicated in sporadic Alzheimer’s disease (sAD);Brain Research;2024-04

3. Post-Finasteride Syndrome And Post-Ssri Sexual Dysfunction: Two Clinical Conditions Apparently Distant, But Very Close;Frontiers in Neuroendocrinology;2024-01

4. Evaluating the neuroprotective effects of progesterone receptors on experimental traumatic brain injury: The PI3K/Akt pathway;Brain and Behavior;2023-09-03

5. Progestogen-Mediated Neuroprotection in Central Nervous System Disorders;Neuroendocrinology;2022-06-27